Latest From TransMedics Inc.
Paragonix Technologies, which developed the first CE-marked and US FDA-cleared medical device system for transporting donor hearts, is ramping-up marketing in Europe and the US while continuing to expand its technology platform to kidney and lung transplants.
A snapshot of global medical device and diagnostics approvals recorded during the past week in Medtech Insight's Approvals Tracker.
TransMedics Organ Care System helps to preserve lungs for transplant, and was recommended for approval despite significant US FDA concerns over trial conduct.
Two US FDA advisory committee meetings are scheduled for May. One will delve into a new organ-transplant device intended to keep organs viable longer, while the other will present recommendations on how the agency should spend funds from the 21st Century Cures Act.
- Medical Devices
- Therapeutic Areas
- Hepatic (Liver)
- Immune Disorders
- North America
- Parent & Subsidiaries
- TransMedics Inc.
- Senior Management
Waleed Hassanein, MD, Pres. & CEO
Stephen Gordon, CFO
Tamer Khayal, MD, Chief Commercial Officer
- Contact Info
Phone: (978) 552-0900
200 Minuteman Rd.
Andover, MA 01810
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.